We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$143M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$19M
3
AGN
Allergan plc
AGN
+$15M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$13.8M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDNT icon
1601
RadNet
RDNT
$6.05B
$334K ﹤0.01%
21,044
– –
BCRX icon
1602
BioCryst Pharmaceuticals
BCRX
$2.49B
$334K ﹤0.01%
70,081
+30,992
+79% +$124K
QNCX icon
1603
Quince Therapeutics
QNCX
$33.9M
$334K ﹤0.01%
36
+9
+33% +$82.5K
NHC icon
1604
National Healthcare
NHC
$3.46B
$333K ﹤0.01%
5,246
– –
ENDP
1605
DELISTED
Endo International plc
ENDP
$332K ﹤0.01%
96,815
– –
GBX icon
1606
The Greenbrier Companies
GBX
$1.42B
$331K ﹤0.01%
14,568
– –
YORW icon
1607
York Water
YORW
$533M
$331K ﹤0.01%
6,906
+1,773
+35% +$76.9K
LASR icon
1608
nLIGHT
LASR
$2.93B
$331K ﹤0.01%
14,866
– –
OSUR icon
1609
OraSure Technologies
OSUR
$276M
$331K ﹤0.01%
28,446
– –
PETQ
1610
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$331K ﹤0.01%
9,493
+1,508
+19% +$42.3K
NTUS
1611
DELISTED
Natus Medical Inc
NTUS
$331K ﹤0.01%
15,157
– –
CASH icon
1612
Pathward Financial
CASH
$1.79B
$330K ﹤0.01%
18,176
+4,227
+30% +$74.1K
AORT icon
1613
Artivion
AORT
$1.39B
$330K ﹤0.01%
17,220
– –
OFIX icon
1614
Orthofix Medical
OFIX
$416M
$330K ﹤0.01%
10,304
+2,744
+36% +$91.1K
SLP icon
1615
Simulations Plus
SLP
$371M
$326K ﹤0.01%
5,451
– –
DMC
1616
Del Monte Corp
DMC
$1.45B
$325K ﹤0.01%
13,189
– –
SSTK icon
1617
Shutterstock
SSTK
$209M
$323K ﹤0.01%
9,230
– –
FBNC icon
1618
First Bancorp
FBNC
$2.73B
$322K ﹤0.01%
12,826
– –
OSG
1619
Octave Specialty Group
OSG
$211M
$321K ﹤0.01%
22,444
– –
MLCO icon
1620
Melco Resorts & Entertainment
MLCO
$2.13B
$321K ﹤0.01%
20,700
+7,500
+57% +$116K
TPIC
1621
DELISTED
TPI Composites
TPIC
$321K ﹤0.01%
13,727
– –
TCRT icon
1622
Alaunos Therapeutics
TCRT
$4.88M
$321K ﹤0.01%
652
+90
+16% +$40.1K
CALX icon
1623
Calix
CALX
$2.53B
$320K ﹤0.01%
21,486
– –
AMRC icon
1624
Ameresco
AMRC
$1.48B
$317K ﹤0.01%
11,403
+1,783
+19% +$35.9K
BATRK icon
1625
Atlanta Braves Holdings Series B
BATRK
$3.42B
$316K ﹤0.01%
16,010
– –
63 64
65
66 67

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.